Limited utility of serum galactomannan assay after auto-SCT

@article{Jathavedam2009LimitedUO,
  title={Limited utility of serum galactomannan assay after auto-SCT},
  author={Ashwin Jathavedam and Dana Dure and Ying Taur and David M. Weinstock},
  journal={Bone Marrow Transplantation},
  year={2009},
  volume={44},
  pages={59-61}
}
Invasive Aspergillosis (IA) is a dreaded infectious complication among immunocompromised patients, including those receiving treatment for hematologic malignancies. Preemptive diagnosis of IA, using serum markers alone or in combination with computed tomography (CT), has received significant attention over the last decade but remains controversial. In 2003, an ELISA to detect serum galactomannan (GM) was approved by the US Food and Drug Administration. In a meta-analysis of 27 studies using the… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 10 references

Rapid test for Aspergillus infection

  • J Sinko, J Csomor, R Nikolova, S Lueff, G Krivan, P Remenyi
  • FDA Consum
  • 2003

Similar Papers

Loading similar papers…